ACORN CAPITAL ADVISORS, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$152.9B
Holdings
21
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1,131,501 | $29.4B | 19.24% | |
| 2 | URGNUROGEN PHARMA LTD | 1,259,749 | $17.3B | 11.29% | |
| 3 | YMABUSDY-MABS THERAPEUTICS INC | 3,418,995 | $15.4B | 10.09% | |
| 4 | PBYIPUMA BIOTECHNOLOGY INC | 4,131,299 | $14.2B | 9.27% | |
| 5 | CADLCANDEL THERAPEUTICS INC | 2,580,517 | $13.1B | 8.54% | |
| 6 | TRVITREVI THERAPEUTICS INC | 2,144,844 | $11.7B | 7.67% | |
| 7 | TERNTERNS PHARMACEUTICALS INC | 1,971,264 | $7.4B | 4.81% | |
| 8 | OKURONKURE THERAPEUTICS INC | 2,839,674 | $6.8B | 4.44% | |
| 9 | HELPCYBIN INC | 734,394 | $6.2B | 4.03% | |
| 10 | BCAXBICARA THERAPEUTICS | 643,382 | $6.0B | 3.91% | |
| 11 | TARAPROTARA THERAPEUTICS INC | 1,752,115 | $5.3B | 3.47% | |
| 12 | CRDFCARDIF ONCOLOGY INC | 1,408,767 | $4.4B | 2.90% | |
| 13 | AURAAURA BIOSCIENCES INC | 595,744 | $3.7B | 2.44% | |
| 14 | VSTMVERASTEM INC | 779,498 | $3.2B | 2.12% | |
| 15 | WHWKWHITEHAWK THERAPEUTICS INC | 1,139,363 | $2.1B | 1.39% | |
| 16 | BCABBIOATLA INC | 4,835,111 | $1.9B | 1.25% | |
| 17 | —MURAL ONCOLOGY PLC | 653,779 | $1.6B | 1.06% | |
| 18 | VYNEVYNE THERAPEUTICS INC | 736,572 | $1.2B | 0.79% | |
| 19 | QTTBQ32 BIO INC. | 803,425 | $1.2B | 0.78% | |
| 20 | ACRVACRIVON THERAPEUTICS INC | 405,237 | $482.2M | 0.32% | |
| 21 | ASNSUSDX4 PHARMACEUTICALS INC | 153,730 | $292.1M | 0.19% |